Developer docs
API playgroundTry for free, no card

Search company profiles

LifeLabs

Full company profile

uuid0002rrp

Namestring
LifeLabs
Legal namestring
LifeLabs LP
Websiteurl
lifelabs.com
Company typeenum
Private
Founded yearint
1998
Descriptiontext

LifeLabs is Canada's largest community diagnostic laboratory network, operating 380+ Patient Service Centres across Ontario, British Columbia, and Saskatchewan alongside 16 laboratories including four reference labs, Canada's largest professional genetic testing laboratory (LifeLabs Genetics), a naturopathic lab (Rocky Mountain Analytical), and a digital health connectivity arm (Excelleris). The business is organized around four core divisions - community lab, genetics, naturopathic testing, and digital health - and runs a broad menu spanning routine chemistry, hematology, microbiology, immunology, molecular diagnostics, anatomic pathology, and specialized testing in oncology, prenatal screening, neurology (Alzheimer's p-tau217), nephrology (Klinrisk), and cardiology. The network performs 112+ million tests annually, serves 9+ million patients per year, and supports 60,000+ healthcare providers through EMR-integrated digital platforms including Rover HIE, eOrder, Launchpad, and the MyCareCompass patient portal (5.4+ million registered users).

Revenue is generated through five distinct streams: provincial public reimbursement under OHIP, MSP, and Saskatchewan Health for the bulk of routine testing; out-of-pocket and private-pay pricing for uncovered specialty tests, at-home kits, and MyVisit mobile appointments (CAD $55-$129+ per transaction); corporate and B2B contracts with employers, hospitals, long-term care facilities, and retirement homes; pharmaceutical solutions spanning clinical trials, sponsored testing, patient support programs, companion diagnostics, and Health Insights data services built on a repository of 8.4+ billion de-identified results; and licensing of digital health connectivity platforms to providers and health authorities. Go-to-market is hybrid: a sales-led and partnership motion targeting HCPs, employers, hospitals, LTC, and pharma clients; a direct-to-consumer storefront (store.lifelabs.com) and at-home channel reaching retail patients; and an emerging clinical trials and real-world data distribution arm.

The business is wholly owned by Quest Diagnostics following a CAD $1.35 billion (including net debt) acquisition from OMERS completed in August 2024, and currently operates as a private subsidiary undergoing a multi-phase restructuring that is transferring Ontario reference laboratory specimens to Quest's U.S. facilities beginning April 6, 2026, while continuing to invest in higher-value specialty testing, AI-enabled precision medicine research via the UBC MOSAIC partnership, and event-based diagnostics tied to FIFA World Cup 2026.

Short descriptiontext

LifeLabs is Canada's largest community diagnostic laboratory network, operating 380+ Patient Service Centres across Ontario, BC, and Saskatchewan and performing 112+ million tests annually for 9+ million patients, 60,000+ healthcare providers, employers, hospitals, and pharmaceutical clients. Wholly owned by Quest Diagnostics since August 2024.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory services, diagnostic testing, medical laboratory network, genetic testing services, patient service centres
Industry6 codes
1Clinical Research & Trial Central Laboratories
CodeHLAFAMALPrimaryYes
2Reference & Esoteric Testing Laboratories
CodeHLAFAMAJPrimaryNo
3Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
CodeHLAGAJAMPrimaryNo
4Central Laboratory Services (Core Lab Operations)
CodeHLAGAEAAPrimaryNo
5Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
CodeHLAGAEABPrimaryNo
6Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
CodeHLAAAMACPrimaryNo
NAICS code4 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Medical and Diagnostic Laboratories62151
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Medical Diagnostic Laboratory Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Provincial Public Healthcare Reimbursement
TypeSubscription Recurring
Description

The majority of LifeLabs' diagnostic tests are covered under provincial health insurance plans (OHIP in Ontario, MSP in British Columbia, Saskatchewan Health Services). Individual diagnostic lab tests are covered for members of provincial health insurance, with the provincial government reimbursing LifeLabs for the cost of approved tests.

lifelabs.com
2Out-of-Pocket / Private Pay Testing
TypeOne Time License
Description

Some tests are not covered by provincial health insurance and are paid directly by patients. These include select specialty tests (e.g., Panorama NIPT, certain genetic tests), at-home collection kits, and MyVisit home appointment services. Pricing ranges from $55 for MyVisit appointments to $129+ for certain tests.

lifelabs.com
3Corporate/B2B Laboratory Services
TypeTransaction Fee
Description

LifeLabs provides contracted laboratory testing services to corporate customers including employers (drug & alcohol screening, medical surveillance, employee wellness), hospitals, long-term care facilities, retirement homes, and clinical trial sponsors. Revenue is generated through service contracts and per-test pricing with these institutional clients.

lifelabs.com
4Pharmaceutical Solutions
TypeProfessional Services
Description

LifeLabs offers clinical trials support, sponsored testing programs, patient support program diagnostics, companion diagnostics, and health insights/real world data services to pharmaceutical companies. This includes end-to-end support from clinical development through commercialization.

lifelabs.com
5Digital Health Solutions Licensing
TypeSubscription Recurring
Description

LifeLabs generates revenue from licensing its digital health platforms (Rover HIE, eOrder, Launchpad EMR viewer, MyCareCompass patient portal) to healthcare providers, health authorities, and pharmaceutical organizations. Services include electronic requisitions, result delivery, and health information exchange.

lifelabs.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details8 tiers
1MyVisit At-Home Appointment - Select (Flexible Scheduling)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$85 per person. Customer chooses date and time with evening and weekend options. LifeLabs technician arrives within a 2-hour window. Services include blood tests, ECG, Holter monitoring, and medical sample collection.

lifelabs.com
2MyVisit At-Home Appointment - Standard
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Starting at $55 per appointment. Customer books, LifeLabs chooses the date and time within 10 business days. Appointment details shared 1-2 days prior. Available in select service areas only.

lifelabs.com
3Pre-Departure COVID-19 PCR/NAAT Testing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

MyVisit pre-departure testing fee is $80 per person. Includes COVID-19 PCR/NAAT swab testing and COVID-19 Antibody Blood (serology) testing. Available for Greater Toronto Area through home visit.

lifelabs.com
4Fecal Immunochemical Test (FIT) Kit - Patient Direct
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$75 cost billed directly to the patient when the kit is returned to LifeLabs. Available for HCPs across Canada except British Columbia as an alternative to Ontario Health's ColonCancerCheck program.

lifelabs.com
5HPV Self-Collection Kit - Patient Direct
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$129 cost billed directly to the patient when kit is returned. Available for HCPs across Canada except British Columbia for patients not eligible for publicly funded screening programs.

lifelabs.com
6Vitamin D At-Home Kit - Patient Direct
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$89 test fee billed directly to the patient when sample is returned. Available for HCPs across Canada except British Columbia. Private-pay option for patients not eligible for public coverage.

lifelabs.com
7FIFA World Cup 2026 Medical Screening Services
ModelUnit PricingBilling cadencePay-as-you-go
Notes

LifeLabs preparing for FIFA World Cup 2026 (June 11 – July 19, 2026) with medical screening services at Toronto and Vancouver venues.

lifelabs.com
8Provincial Health Insurance (OHIP/MSP/Saskatchewan)
ModelSubscriptionBilling cadenceAnnual
Notes

Individual diagnostic lab tests are often covered under provincial health insurance. Although most routine tests are covered, some tests may not be covered. Patients advised to check with private health insurance for potential coverage of uninsured tests.

lifelabs.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 6 records shown
1Panorama
Description

Non-Invasive Prenatal Test (NIPT) that screens for common genetic conditions caused by extra or missing chromosomes in the baby's DNA, available from 9 weeks gestation.

lifelabs.com
+5 more records
Core offering1 text field

LifeLabs is Canada's largest community medical diagnostic laboratory network, operating 380+ Patient Service Centres and 16 state-of-the-art laboratories across Ontario, British Columbia, and Saskatchewan. The company performs over 112 million laboratory tests annually for more than 9 million patients, spanning routine clinical chemistry, hematology, microbiology, molecular diagnostics, genetic testing (NIPT, hereditary cancer panels), cardiac monitoring, and specialty oncology testing. It also operates digital health platforms (Rover HIE, eOrder, Launchpad, MyCareCompass) and serves corporate customers including hospitals, employers, long-term care facilities, and pharmaceutical companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Over 112 million laboratory tests performed annually, serving over 9 million patients per year
+7 more records
Product overview1 text field

LifeLabs is Canada's largest community laboratory, operating as a unified platform spanning diagnostic testing, genetics, oncology, and digital health across four divisions: LifeLabs (core community lab), LifeLabs Genetics (clinical genetic testing and counselling), Rocky Mountain Analytical (naturopathic testing), and Excelleris (digital connectivity). The company performs over 112 million laboratory tests annually across a network of over 380 Patient Service Centres in Ontario, British Columbia, and Saskatchewan, serving more than 9 million patients and facilitating testing for over 60,000 healthcare providers. The product portfolio centers on core diagnostic services (routine and specialized clinical lab tests), supplemented by advanced oncology products (Signatera MRD, Hereditary Cancer Panel, PSA, FIT), genetic testing (Panorama NIPT, AMH), cardiac monitoring (ECG, Holter, ABPM), and digital health platforms (Rover HIE, eOrder requisition system, Launchpad EMR viewer, MyCareCompass patient portal). LifeLabs' corporate offerings include clinical trials services, pharma solutions (sponsored testing, patient support programs, companion diagnostics, health insights), and employer services (drug screening, medical surveillance, employee wellness). Mobile collection (MyVisit) and Point of Care Testing (POCT) extend laboratory services into non-traditional settings.

Product and service13 records
1LifeLabs Core Diagnostic Laboratory Services
CategoryDiagnostic Laboratory Services
Description

Core medical diagnostic laboratory services including specimen collection, routine chemistry, hematology, microbiology, immunology, molecular diagnostics, and results reporting for individual patients, healthcare providers, hospitals, and corporate customers. Performs over 112 million tests annually for more than 9 million patients.

2Panorama Non-Invasive Prenatal Test (NIPT)
CategoryGenetic Testing
Description

A Non-Invasive Prenatal Test that screens for common genetic conditions caused by extra or missing chromosomes in the baby's DNA as early as 9 weeks, analyzing placental DNA through a simple maternal blood draw.

3Signatera Molecular Residual Disease (MRD) Test
CategoryOncology Testing
Description

A highly sensitive and personalized molecular residual disease (MRD) test using circulating tumor DNA (ctDNA), custom-designed for each patient to help quantify tumour burden and identify relapse earlier than standard of care tools. Appropriate for patients diagnosed with solid tumour cancers.

4Hereditary Cancer Panel
CategoryGenetic Testing
Description

Comprehensive panel including full sequencing and copy number variant analyses of 84 genes associated with increased risk of hereditary breast, ovarian, uterine, colorectal, gastric, prostate, melanoma, and pancreatic cancer.

5PSA (Prostate-Specific Antigen) Test
CategoryOncology Testing
Description

A simple blood test that helps assess a man's risk of prostate cancer. One in eight men in Canada will be diagnosed with prostate cancer in their lifetime. Available at LifeLabs Patient Service Centres and via online purchase.

6Fecal Immunochemical Test (FIT)
CategoryOncology Testing
Description

A safe, painless, stool-based screening test for people at average risk of developing colorectal cancer, checking for the presence of occult blood as an early sign of colorectal cancer and/or pre-cancerous lesions. Available as a $75 patient direct kit option.

7Alzheimer's Aβ42/40 with p-tau217 Testing
CategorySpecialty Diagnostic Testing
Description

A portfolio of blood-based biomarker tests for Alzheimer's disease risk assessment, including p-tau217 testing for early detection of Alzheimer's disease pathology. Announced April 21, 2026.

8Electrocardiogram (ECG)
CategoryCardiac Monitoring
Description

An electrocardiogram (ECG/EKG) records how the heart is functioning by measuring its electrical activity through sensors placed on the chest, arms, and lower legs. A simple procedure completed in as quickly as 15 minutes at select Patient Service Centres.

9Holter Monitoring
CategoryCardiac Monitoring
Description

A small, lightweight wearable device that continuously records the heart rhythm for 24 hours up to 14 days, allowing physicians to determine if there are intermittent abnormalities to the heart rhythm (arrhythmias) over an extended period.

1024-Hour Ambulatory Blood Pressure Monitoring (ABPM)
CategoryCardiac Monitoring
Description

A wearable device that monitors blood pressure over 24 hours at regular intervals (typically every 15–30 minutes), providing a more reliable measurement than a single office reading for clinical decision-making.

11HbA1c Diabetes Health Kit
CategoryAt-Home Health Testing
Description

An at-home blood collection kit for HbA1c testing that tracks average blood sugar levels over the past three months to detect diabetes and prediabetes early, manage diabetes effectively, and maintain long-term health.

12Vitamin D Health (25-Hydroxy) Test
CategoryAt-Home Health Testing
Description

A blood test measuring 25-Hydroxy Vitamin D levels to help determine if a patient has adequate vitamin D for calcium absorption, bone growth, and prevention of osteoporosis. Available as $89 patient direct kit.

13HPV Testing
Scale indicator20 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-16
Description

UBC's MOSAIC research team partnered with LifeLabs to advance cardiovascular health care in British Columbia using advanced heart imaging, genomics, and AI to detect early signs of heart disease and improve risk prediction. LifeLabs provides sample collection through its network of 129 patient service centres across BC, enabling easier participation for residents including those in rural and remote communities. The initiative is part of the Canadian Precision Health Initiative, funded by Genome Canada and Genome BC, which aims to build a dataset of 100,000 Canadians to advance precision medicine.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Interior Health, in collaboration with LifeLabs and community members, formed a working group in January 2026 to preserve lab services at the Trail Community Health Centre. Services continue with workflow improvements in place and positive recruitment signs with more staff expected over the coming months. Interior Health had previously announced the blood lab would close before relenting after community pushback.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2017-09-01
Description

LifeLabs partnership with POGO began in 2017, providing customized care packages and treasure baskets to children undergoing cancer treatment at POGO Satellite Clinics in Ontario starting September 2025. The initiative aims to provide comfort and support to families affected by childhood cancer.

4Major Canadian EMR Vendors (Rover HIE Integration)
Strategic tierCoreTypeTechnology or Integration
Description

LifeLabs' Rover Health Information Exchange platform is integrated with most major electronic medical record (EMR) companies in Canada, including LifeLabs' own EMR viewer Launchpad, digital health patient portal MyCareCompass, and a variety of other public and private systems. This enables digital distribution of medical information to healthcare providers across Canada.

lifelabs.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat6 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LifeLabs

Medical Diagnostic Laboratory Serviceslifelabs.com

LifeLabs is Canada's largest community diagnostic laboratory network, operating 380+ Patient Service Centres across Ontario, BC, and Saskatchewan and performing 112+ million tests annually for 9+ million patients, 60,000+ healthcare providers, employers, hospitals, and pharmaceutical clients. Wholly owned by Quest Diagnostics since August 2024.

What LifeLabs does

LifeLabs is Canada's largest community diagnostic laboratory network, operating 380+ Patient Service Centres across Ontario, British Columbia, and Saskatchewan alongside 16 laboratories including four reference labs, Canada's largest professional genetic testing laboratory (LifeLabs Genetics), a naturopathic lab (Rocky Mountain Analytical), and a digital health connectivity arm (Excelleris). The business is organized around four core divisions - community lab, genetics, naturopathic testing, and digital health - and runs a broad menu spanning routine chemistry, hematology, microbiology, immunology, molecular diagnostics, anatomic pathology, and specialized testing in oncology, prenatal screening, neurology (Alzheimer's p-tau217), nephrology (Klinrisk), and cardiology. The network performs 112+ million tests annually, serves 9+ million patients per year, and supports 60,000+ healthcare providers through EMR-integrated digital platforms including Rover HIE, eOrder, Launchpad, and the MyCareCompass patient portal (5.4+ million registered users).

Revenue is generated through five distinct streams: provincial public reimbursement under OHIP, MSP, and Saskatchewan Health for the bulk of routine testing; out-of-pocket and private-pay pricing for uncovered specialty tests, at-home kits, and MyVisit mobile appointments (CAD $55-$129+ per transaction); corporate and B2B contracts with employers, hospitals, long-term care facilities, and retirement homes; pharmaceutical solutions spanning clinical trials, sponsored testing, patient support programs, companion diagnostics, and Health Insights data services built on a repository of 8.4+ billion de-identified results; and licensing of digital health connectivity platforms to providers and health authorities. Go-to-market is hybrid: a sales-led and partnership motion targeting HCPs, employers, hospitals, LTC, and pharma clients; a direct-to-consumer storefront (store.lifelabs.com) and at-home channel reaching retail patients; and an emerging clinical trials and real-world data distribution arm.

The business is wholly owned by Quest Diagnostics following a CAD $1.35 billion (including net debt) acquisition from OMERS completed in August 2024, and currently operates as a private subsidiary undergoing a multi-phase restructuring that is transferring Ontario reference laboratory specimens to Quest's U.S. facilities beginning April 6, 2026, while continuing to invest in higher-value specialty testing, AI-enabled precision medicine research via the UBC MOSAIC partnership, and event-based diagnostics tied to FIFA World Cup 2026.

LifeLabs firmographics

Firmographics
Name
LifeLabs
Legal name
LifeLabs LP
Website
https://lifelabs.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
LifeLabs is Canada's largest community diagnostic laboratory network, operating 380+ Patient Service Centres across Ontario, BC, and Saskatchewan and performing 112+ million tests annually for 9+ million patients, 60,000+ healthcare providers, employers, hospitals, and pharmaceutical clients. Wholly owned by Quest Diagnostics since August 2024.
Ownership category
akta.pro rank

LifeLabs industry classification

Industry
Product category
Medical Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro primary industry
Clinical Research & Trial Central Laboratories (HLAFAMAL)
akta.pro secondary industries
Reference & Esoteric Testing Laboratories (HLAFAMAJ), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

  • Clinical laboratory services
  • Diagnostic testing
  • Medical laboratory network
  • Genetic testing services
  • Patient service centres

Where LifeLabs is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices6 records

Markets served

LifeLabs business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Provincial Public Healthcare Reimbursement: The majority of LifeLabs' diagnostic tests are covered under provincial health insurance plans (OHIP in Ontario, MSP in British Columbia, Saskatchewan Health Services). Individual diagnostic lab tests are covered for members of provincial health insurance, with the provincial government reimbursing LifeLabs for the cost of approved tests.
  2. Out-of-Pocket / Private Pay Testing: Some tests are not covered by provincial health insurance and are paid directly by patients. These include select specialty tests (e.g., Panorama NIPT, certain genetic tests), at-home collection kits, and MyVisit home appointment services. Pricing ranges from $55 for MyVisit appointments to $129+ for certain tests.
  3. Corporate/B2B Laboratory Services: LifeLabs provides contracted laboratory testing services to corporate customers including employers (drug & alcohol screening, medical surveillance, employee wellness), hospitals, long-term care facilities, retirement homes, and clinical trial sponsors. Revenue is generated through service contracts and per-test pricing with these institutional clients.
  4. Pharmaceutical Solutions: LifeLabs offers clinical trials support, sponsored testing programs, patient support program diagnostics, companion diagnostics, and health insights/real world data services to pharmaceutical companies. This includes end-to-end support from clinical development through commercialization.
  5. Digital Health Solutions Licensing: LifeLabs generates revenue from licensing its digital health platforms (Rover HIE, eOrder, Launchpad EMR viewer, MyCareCompass patient portal) to healthcare providers, health authorities, and pharmaceutical organizations. Services include electronic requisitions, result delivery, and health information exchange.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goMyVisit At-Home Appointment - Select (Flexible Scheduling)
Unit PricingPay-as-you-goMyVisit At-Home Appointment - Standard
Unit PricingPay-as-you-goPre-Departure COVID-19 PCR/NAAT Testing
Unit PricingPay-as-you-goFecal Immunochemical Test (FIT) Kit - Patient Direct
Unit PricingPay-as-you-goHPV Self-Collection Kit - Patient Direct
Unit PricingPay-as-you-goVitamin D At-Home Kit - Patient Direct
Unit PricingPay-as-you-goFIFA World Cup 2026 Medical Screening Services
SubscriptionAnnualProvincial Health Insurance (OHIP/MSP/Saskatchewan)

Go-to-market motion3 records

Distribution channels7 records

Marketing channels9 records

LifeLabs product offering

Product offering

Core offering

LifeLabs is Canada's largest community medical diagnostic laboratory network, operating 380+ Patient Service Centres and 16 state-of-the-art laboratories across Ontario, British Columbia, and Saskatchewan. The company performs over 112 million laboratory tests annually for more than 9 million patients, spanning routine clinical chemistry, hematology, microbiology, molecular diagnostics, genetic testing (NIPT, hereditary cancer panels), cardiac monitoring, and specialty oncology testing. It also operates digital health platforms (Rover HIE, eOrder, Launchpad, MyCareCompass) and serves corporate customers including hospitals, employers, long-term care facilities, and pharmaceutical companies.

Product overview

LifeLabs is Canada's largest community laboratory, operating as a unified platform spanning diagnostic testing, genetics, oncology, and digital health across four divisions: LifeLabs (core community lab), LifeLabs Genetics (clinical genetic testing and counselling), Rocky Mountain Analytical (naturopathic testing), and Excelleris (digital connectivity). The company performs over 112 million laboratory tests annually across a network of over 380 Patient Service Centres in Ontario, British Columbia, and Saskatchewan, serving more than 9 million patients and facilitating testing for over 60,000 healthcare providers. The product portfolio centers on core diagnostic services (routine and specialized clinical lab tests), supplemented by advanced oncology products (Signatera MRD, Hereditary Cancer Panel, PSA, FIT), genetic testing (Panorama NIPT, AMH), cardiac monitoring (ECG, Holter, ABPM), and digital health platforms (Rover HIE, eOrder requisition system, Launchpad EMR viewer, MyCareCompass patient portal). LifeLabs' corporate offerings include clinical trials services, pharma solutions (sponsored testing, patient support programs, companion diagnostics, health insights), and employer services (drug screening, medical surveillance, employee wellness). Mobile collection (MyVisit) and Point of Care Testing (POCT) extend laboratory services into non-traditional settings.

Differentiator

Problem solved

Functional benefit

Brands

  • Panorama: Non-Invasive Prenatal Test (NIPT) that screens for common genetic conditions caused by extra or missing chromosomes in the baby's DNA, available from 9 weeks gestation.
  • Signatera
  • MyCareCompass
  • MyVisit
  • launchpad
  • POCT

Products and services

  • LifeLabs Core Diagnostic Laboratory Services Core medical diagnostic laboratory services including specimen collection, routine chemistry, hematology, microbiology, immunology, molecular diagnostics, and results reporting for individual patients, healthcare providers, hospitals, and corporate customers. Performs over 112 million tests annually for more than 9 million patients.
  • Panorama Non-Invasive Prenatal Test (NIPT) A Non-Invasive Prenatal Test that screens for common genetic conditions caused by extra or missing chromosomes in the baby's DNA as early as 9 weeks, analyzing placental DNA through a simple maternal blood draw.
  • Signatera Molecular Residual Disease (MRD) Test A highly sensitive and personalized molecular residual disease (MRD) test using circulating tumor DNA (ctDNA), custom-designed for each patient to help quantify tumour burden and identify relapse earlier than standard of care tools. Appropriate for patients diagnosed with solid tumour cancers.
  • Hereditary Cancer Panel Comprehensive panel including full sequencing and copy number variant analyses of 84 genes associated with increased risk of hereditary breast, ovarian, uterine, colorectal, gastric, prostate, melanoma, and pancreatic cancer.
  • PSA (Prostate-Specific Antigen) Test A simple blood test that helps assess a man's risk of prostate cancer. One in eight men in Canada will be diagnosed with prostate cancer in their lifetime. Available at LifeLabs Patient Service Centres and via online purchase.
  • Fecal Immunochemical Test (FIT) A safe, painless, stool-based screening test for people at average risk of developing colorectal cancer, checking for the presence of occult blood as an early sign of colorectal cancer and/or pre-cancerous lesions. Available as a $75 patient direct kit option.
  • Alzheimer's Aβ42/40 with p-tau217 Testing A portfolio of blood-based biomarker tests for Alzheimer's disease risk assessment, including p-tau217 testing for early detection of Alzheimer's disease pathology. Announced April 21, 2026.
  • Electrocardiogram (ECG) An electrocardiogram (ECG/EKG) records how the heart is functioning by measuring its electrical activity through sensors placed on the chest, arms, and lower legs. A simple procedure completed in as quickly as 15 minutes at select Patient Service Centres.
  • Holter Monitoring A small, lightweight wearable device that continuously records the heart rhythm for 24 hours up to 14 days, allowing physicians to determine if there are intermittent abnormalities to the heart rhythm (arrhythmias) over an extended period.
  • 24-Hour Ambulatory Blood Pressure Monitoring (ABPM) A wearable device that monitors blood pressure over 24 hours at regular intervals (typically every 15–30 minutes), providing a more reliable measurement than a single office reading for clinical decision-making.
  • HbA1c Diabetes Health Kit An at-home blood collection kit for HbA1c testing that tracks average blood sugar levels over the past three months to detect diabetes and prediabetes early, manage diabetes effectively, and maintain long-term health.
  • Vitamin D Health (25-Hydroxy) Test A blood test measuring 25-Hydroxy Vitamin D levels to help determine if a patient has adequate vitamin D for calcium absorption, bone growth, and prevention of osteoporosis. Available as $89 patient direct kit.
  • HPV Testing

Quantifiable outcome

  • Over 112 million laboratory tests performed annually, serving over 9 million patients per year
  • +7 more outcomes

Companies that use LifeLabs

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles6 records

LifeLabs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability3 records

Feature12 records

LifeLabs partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • University of British Columbia (MOSAIC Research Team)coreStrategic or Co-development Partner · 16 June 2026UBC's MOSAIC research team partnered with LifeLabs to advance cardiovascular health care in British Columbia using advanced heart imaging, genomics, and AI to detect early signs of heart disease and improve risk prediction. LifeLabs provides sample collection through its network of 129 patient service centres across BC, enabling easier participation for residents including those in rural and remote communities. The initiative is part of the Canadian Precision Health Initiative, funded by Genome Canada and Genome BC, which aims to build a dataset of 100,000 Canadians to advance precision medicine.
  • Interior Health AuthorityminorStrategic or Co-development Partner · 1 January 2026Interior Health, in collaboration with LifeLabs and community members, formed a working group in January 2026 to preserve lab services at the Trail Community Health Centre. Services continue with workflow improvements in place and positive recruitment signs with more staff expected over the coming months. Interior Health had previously announced the blood lab would close before relenting after community pushback.
  • POGO (Pediatric Oncology Group of Ontario)minorStrategic or Co-development Partner · 1 September 2017LifeLabs partnership with POGO began in 2017, providing customized care packages and treasure baskets to children undergoing cancer treatment at POGO Satellite Clinics in Ontario starting September 2025. The initiative aims to provide comfort and support to families affected by childhood cancer.
  • Major Canadian EMR Vendors (Rover HIE Integration)coreTechnology or IntegrationLifeLabs' Rover Health Information Exchange platform is integrated with most major electronic medical record (EMR) companies in Canada, including LifeLabs' own EMR viewer Launchpad, digital health patient portal MyCareCompass, and a variety of other public and private systems. This enables digital distribution of medical information to healthcare providers across Canada.

Scale indicators20 records

Recent moves7 records

Expansion highlights6 records

LifeLabs competitors and assessment

Company assessment

Market position

Competitive moat6 records

Key highlights7 records

Customer concentration

LifeLabs social profiles

Digital presence

LifeLabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LifeLabs leadership team

Management profile

Number of profiles

Profiles7 records

LifeLabs subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

LifeLabs funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LifeLabs M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeLabs

What does LifeLabs do?

LifeLabs is Canada's largest community medical diagnostic laboratory network, operating 380+ Patient Service Centres and 16 state-of-the-art laboratories across Ontario, British Columbia, and Saskatchewan. The company performs over 112 million laboratory tests annually for more than 9 million patients, spanning routine clinical chemistry, hematology, microbiology, molecular diagnostics, genetic testing (NIPT, hereditary cancer panels), cardiac monitoring, and specialty oncology testing. It also operates digital health platforms (Rover HIE, eOrder, Launchpad, MyCareCompass) and serves corporate customers including hospitals, employers, long-term care facilities, and pharmaceutical companies.

Is LifeLabs a public or private company?

LifeLabs is a private company. It is classified as corporate owned and is currently operating.

When was LifeLabs founded?

LifeLabs was founded in 1998. It employs 5,001 to 10,000 people.

Where is LifeLabs based?

LifeLabs is headquartered in Toronto, Canada, in the North America region.

How does LifeLabs make money?

Five revenue lines are on record. Provincial Public Healthcare Reimbursement is the primary driver. The others are out-of-Pocket / Private Pay Testing, corporate/B2B Laboratory Services, pharmaceutical Solutions and digital Health Solutions Licensing.

Does LifeLabs have an API?

No public API is recorded for LifeLabs.

What industry is LifeLabs in?

LifeLabs's product category is Medical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAL, Clinical Research & Trial Central Laboratories, with a secondary code of HLAFAMAJ, Reference & Esoteric Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Financial PostErica Zarkovich, Chief Market and Partnerships Officer, Named One of Canada's Most Powerful Women: Top 100Erica Zarkovich, Chief Market and Partnerships Officer at LifeLabs, was named to WXN's Canada's Most Powerful Women: Top 100 list for 2026 in the CN Executive Leaders category. The recognition highlights her leadership in healthcare, including strategic alliances and expanded diagnostic access. Her work has elevated LifeLabs' role as a trusted healthcare partner.Financial PostLifeLabs Celebrates 11 Family Scholarship Recipients for 2026LifeLabs announced 11 scholarship recipients for its 2026 Family Scholarship Program, selected from employees' dependent children. The recipients will pursue bachelor's degrees in fields such as Business, Arts, Science, Nursing, and Applied Science. The company thanked its insurance partner The Co-operators for continued support.MDPIAge-Specific Antibiograms for Bacterial Meningitis Pathogens Based on Isolates Collected in a Community LaboratoryResearchers created age-specific antibiograms using LifeLabs data to analyze bacterial meningitis pathogen susceptibility patterns on Vancouver Island from January 2023 to December 2024, finding that 78 of 83 Streptococcus pneumoniae isolates were susceptible to ceftriaxone using meningitis breakpoints. The study identified significant age-specific differences in ciprofloxacin susceptibility, with rates declining from 82% in patients under 18 to 75% in those over 50. The authors conclude that ceftriaxone should remain the drug of choice for community-acquired bacterial meningitis and may be sufficient as monotherapy for pneumococcal meningitis on Vancouver Island.GlobeNewswireUBC MOSAIC and LifeLabs Unlock New Ways to Manage and Predict Heart HealthThe University of British Columbia's MOSAIC research team has partnered with LifeLabs to advance cardiovascular health care in British Columbia using advanced heart imaging, genomics, and artificial intelligence to detect early signs of heart disease and improve risk prediction. LifeLabs is supporting the initiative by providing sample collection through its network of 129 patient service centers across the province, enabling easier participation for residents including those in rural and remote communities. The initiative is part of the Canadian Precision Health Initiative, funded by Genome Canada and Genome BC, which aims to build a dataset of 100,000 Canadians to advance precision medicine.Financial PostHealth Coalition Issues Open Letter to Health Minister to Stop Transfer of Lab Testing by Quest/Lifelabs to U.S.The Ontario Health Coalition has issued an open letter to Ontario Health Minister Sylvia Jones urging her to halt Quest Diagnostics from transferring laboratory specimens from Ontario patients to Quest's reference laboratories in the United States. In August 2024, Quest completed its acquisition of LifeLabs and has since reduced staffing at its Sudbury facility by half, cancelled afternoon hours at the Kenora lab, and plans to transition reference laboratory tests to U.S. facilities in three phases beginning April 6, 2026. The Coalition warns that the transfer raises patient privacy concerns, reduces hospital revenue, jeopardizes specimen quality through increased transportation times, and sends Ontario healthcare dollars abroad.Financial PostLifeLabs Recognized Once Again by Forbes as One of Canada's Best Employers for 2026LifeLabs was recognized by Forbes as one of Canada's Best Employers for 2026 during an award based on a survey of over 37,000 Canadian employees. The recognition highlights the company's commitment to quality diagnostic services and its strong corporate culture.GlobeNewswireLifeLabs Recognized Once Again by Forbes as One of Canada’s Best Employers for 2026LifeLabs has been named one of Canada's Best Employers for 2026 by Forbes Canada, based on an independent survey of over 37,000 Canada-based employees working for organizations with at least 500 employees. The recognition reflects LifeLabs' company culture and the trust Canadians place in the diagnostic services they provide across their network of Patient Service Centres, laboratories, and logistics operations. This award continues LifeLabs' track record of Forbes recognitions, including previous Best Employers honors in 2021, 2022, and 2023.openPR.comFuture Prospects: Key Trends Shaping the Diagnostics-As-A-Service Market Until 2030The diagnostics-as-a-service market is projected to grow to $13.88 billion by 2030 at a compound annual growth rate of 20.7%, driven by increased demand for real-time diagnostics, AI-powered clinical decision support systems, and decentralized healthcare delivery. In August 2024, Quest Diagnostics acquired LifeLabs to expand its diagnostics-as-a-service capabilities across North America, combining Quest's advanced laboratory services with LifeLabs' community laboratory network and digital health systems. The market encompasses diverse segments including software, services, and platforms deployed across clinical diagnostics, imaging, pathology, and genomics applications.Financial PostCelebrating National Medical Laboratory WeekLifeLabs, Canada's leading provider of medical diagnostic services, issued a recognition statement for National Medical Laboratory Week (NMLW), celebrating the contributions of medical laboratory professionals whose work provides diagnostic insights for patient care.GlobeNewswireCelebrating National Medical Laboratory WeekLifeLabs is celebrating National Medical Laboratory Week with the theme 'Lab Story: To Infinity and Beyond for Our Patients.' CEO Charles Brown highlighted the vital role of laboratory professionals in patient care. The company supports over 15 million patient visits annually and conducts over 140 million tests.